Manimaran, D., Elangovan, N., & Palanisamy, V. (2024). Anti-Tumorgenic Impact of Nano-Formulated Peptide HIF-Alpha Therapy by DMBA Induced Mammary Carcinoma in Rodent Type. Jordan Journal of Pharmaceutical Sciences, 17(4), 783–793. https://doi.org/10.35516/jjps.v17i4.2482